Boai NKY Medical Holdings (SZSE:300109) Risk Assessment

View and export this data going back to 2010. Start your Free Trial

What is Boai NKY Medical Holdings Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Boai NKY Medical Holdings is: Moderate Risk: Sensitive, better choose undervalued stock.

Competitive Comparison of Boai NKY Medical Holdings's Risk Assessment

For the Specialty Chemicals subindustry, Boai NKY Medical Holdings's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Boai NKY Medical Holdings's Risk Assessment Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Boai NKY Medical Holdings's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Boai NKY Medical Holdings's Risk Assessment falls into.

Save Embed

;

Save Embed

;

Boai NKY Medical Holdings (SZSE:300109) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Boai NKY Medical Holdings Risk Assessment Related Terms

Thank you for viewing the detailed overview of Boai NKY Medical Holdings's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Boai NKY Medical Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Boai NKY Medical Holdings Ltd (SZSE:300109) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1888, Wenhua Road (East Section), Boai county, Henan Province, Jiaozuo, CHN, 454450

Website

http://www.nkygroup.cn

Boai NKY Medical Holdings Ltd is engaged in Research and development, production of pharmaceutical excipients, APIs (povidone-iodine), adhesives, food additives (insoluble polyvinyl polypyrrolidone); polyvinyl pyrrolidone series products, vinyl methyl ether/maleic anhydride polymers.

Executives

Li She Gang	Executives
Zou Xiao Wen	Executives
Zhang Jun Zheng	Directors, executives
Yang Hong Bo	Director
Wang Dong Hu	Director
Ren Da Long	Director
Xing Xiao Liang	Directors, executives
Wang Shi Gang	Executives
Wang Xin Meng	Executives
Qu Yun Xia	Supervisors
Wang Jian Qiang	Director
Yang Hai Jiang	Director
Yan Zhong Chao	Supervisors
Liu Ai Min	Executives
Wu Cong Zhou	Executives

Boai NKY Medical Holdings Headlines

No Headlines